As FAK can regulate β-catenin levels in colon carcinoma cells (Gao et al., 2015), the mass spectrometry results implicate intrinsic FAK activity in supporting Wnt-β-catenin signaling in KMF cells. The gene discussed is PTK2; the disease is colon carcinoma.